Study Evaluation of the Efficacy, Safety and Immunogenicity of Adalimumab in Comparison With Humira ®
Condition: Plaque Psoriasis Interventions: Drug: Adalimumab; Drug: Humira Sponsor: Mabscale, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
